Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs
Clinical trial NCT06160167 · COMPLETED
Trial details
- NCT number
- NCT06160167
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-01
- Primary completion
- 2024-08-01
- Enrollment
- 4204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.